Scarica l'app Stockscreener
2.62
3.97%
0.10
Black Diamond Therapeutics Inc Borsa (BDTX) Ultime notizie
BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight - GlobeNewswire
BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
Barclays PLC Has $339,000 Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Critical Comparison: Black Diamond Therapeutics (NASDAQ:BDTX) & Cardiol Therapeutics (NASDAQ:CRDL) - Defense World
3 US Penny Stocks With Market Caps Under $200M - Simply Wall St
Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre-market Movers: SAGE, ITCI, GCTK, MRNA... - RTTNews
Raymond James Predicts Up to ~930% Rally for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Are Medical Stocks Lagging Aptevo Therapeutics (APVO) This Year? - Yahoo Finance
BDTX stock touches 52-week low at $2.08 amid market challenges - Investing.com
Roche purchases shares in tender offer for Poseida Therapeutics, Inc. - Yahoo Finance
Soleno Therapeutics, Inc. (NASDAQ:SLNO): When Will It Breakeven? - Yahoo Finance
XORTX Adds Late Stage Gout Program to Pipeline - Yahoo Finance
Geode Capital Management LLC Raises Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Geode Capital Management LLC Grows Stock Holdings in BARK, Inc. (NYSE:BARK) - Defense World
Barclays PLC Acquires 11,273 Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV) - Defense World
Geode Capital Management LLC Buys 50,579 Shares of Design Therapeutics, Inc. (NASDAQ:DSGN) - Defense World
Barclays PLC Has $339,000 Stock Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Why Is Summit Therapeutics Inc. (SMMT) Among the Best Multibagger Stocks to Buy Right Now? - Yahoo Finance
State Street Corp Buys 118,764 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics: Speculative Buy With Precision Oncology Catalysts (BDTX) - Seeking Alpha
Barclays PLC Has $1.10 Million Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World
Sarepta Therapeutics, Inc. (SRPT): Is This Gene Therapy Stock a Good Buy Right Now? - Yahoo Finance
Analysts Expect Breakeven For Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Before Long - Yahoo Finance
Will TG Therapeutics, Inc. (TGTX) Make You Rich In 2025? - Yahoo Finance
Is Sarepta Therapeutics, Inc. (SRPT) the Best Performing Biotech Stock in 2024? - Yahoo Finance
Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) biggest owners are retail investors who got richer after stock soared 17% last week - Yahoo Finance
Charles Schwab Investment Management Inc. Boosts Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
BDTX stock touches 52-week low at $2.31 amid market challenges - Investing.com India
Analytical Overview: Black Diamond Therapeutics Inc (BDTX)’s Ratios Tell a Financial Story - The Dwinnex
Fmr LLC Makes New Investment in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Akava Therapeutics, Inc. congratulates SAB Chair Dr. Hande Ozdinler, Founder Dr. Richard B. Silverman, and Dr. William Klein on their recent grant of $7.3 million from the National Institute on Aging to investigate AKV9 in neurodegenerative diseases - Yahoo Finance
Checkpoint stock on watch after FDA nod (CKPT:NASDAQ) - Seeking Alpha
US Penny Stocks Spotlight: Information Services Group Among 3 Top Picks - Simply Wall St
Black Diamond (BDTX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Fmr LLC Decreases Stock Position in Mobileye Global Inc. (NASDAQ:MBLY) - Defense World
MFA Financial, Inc. (NYSE:MFA) Shares Sold by Fmr LLC - Defense World
BNP Paribas Financial Markets Purchases 111,027 Shares of Under Armour, Inc. (NYSE:UA) - Defense World
Fmr LLC Has $15.49 Million Stake in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
MetLife Investment Management LLC Raises Stake in Smith-Midland Co. (NASDAQ:SMID) - Defense World
BNP Paribas Financial Markets Raises Stake in RadNet, Inc. (NASDAQ:RDNT) - Defense World
Fmr LLC Increases Position in AppFolio, Inc. (NASDAQ:APPF) - Defense World
Fmr LLC Raises Stock Position in ADT Inc. (NYSE:ADT) - Defense World
Charles Schwab Investment Management Inc. Sells 309,336 Shares of Unisys Co. (NYSE:UIS) - Defense World
Oruka Therapeutics, Inc. (NASDAQ:ORKA) institutional investors have had a good week as stock gains 15% - Yahoo Finance
Point72 Asset Management L.P. Takes $3.03 Million Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - MarketBeat
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) has caught the attention of institutional investors who hold a sizeable 42% stake - Yahoo Finance
The number of Black Fortune 500 CEOs is still abysmally low. A ‘shocking’ corporate DEI practice might be to blame, Stanford professor says - Yahoo Finance
Biopharma’s Shopping Spree, Applied Crashes on Rejection, Skysona’s Safety Concerns, More - BioSpace
vTv Therapeutics to Participate in 7th Annual Evercore HealthCONx Conference - Yahoo Finance
Vestal Point Capital LP Purchases 2,928,500 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - MarketBeat
Gene and Cell Therapies Targeting CNS Disorders Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight - The Globe and Mail
Gene and Cell Therapies Targeting CNS Disorders Treatment - openPR
Vorasidenib Improves PFS, Shows Tumor Reduction in IDH1/2+ Glioma - Cancer Network
Breakeven On The Horizon For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) - Yahoo Finance
Poseida Therapeutics, Inc. (PSTX) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Genesis Therapeutics presents new PI3Kα mutant inhibitors - BioWorld Online
Roche's Proposed Acquisition Of Poseida Therapeutics Poised To Establish New Core Capability In Cell Therapy For Cancer And Autoimmune Diseases: Details - Yahoo Finance
Vorasidenib Shows Consistent Efficacy With Manageable Safety in IDH1/2-Mutant Diffuse Glioma - OncLive
Stoke Therapeutics (STOK) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
3.95%
2.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):